Skip to main content

Table 3 Grade 3/4 (CTCAE v3.0) bladder and bowel late complications after PET-guided extended-field dose-escalating chemo-IMRT/3D-brachytherapy

From: Patterns of failure after use of 18F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases

Patient number (%)

Supraclavicular, 15

Paraaortic, 31

Pelvic, 26

Total, 72

Bladder

3 (4.2)

 Cystitis

0

1

1

2

 Vesicovaginal fistula

0

1

0

1

Bowel

7 (9.7)

 Rectal ulcer

1

0

0

1

 Proctitis

1

0

0

1

 Rectovaginal fistula

1

1

1

3

 Bowel obstruction

0

1

1

2

  1. Abbreviations: CTCAE v3.0 common terminology criteria for adverse events, version toxicity, IMRT/IGRT intensity-modulated and image-guided radiotherapy, PET fluorodeoxyglucose position emission computed tomography